Abstract
To study the “natural history” of breast cancer implies observing a large number of patients over a long period without any medical intervention. Clearly this has been considered unethical in the modern era yet without knowing the natural history of the untreated disease it becomes impossible to judge the impact of treatment. The modern era can be considered to start in the early 19th century with the innovations in anaesthesia and antisepsis that within a few decades allowed for the introduction of the Halsted radical mastectomy. Since then we have had to deduce the natural history of disease in retrospect. Along the way a better understanding of the nature and biology of cancer has emerged that contributed to the replacement of radical surgery with ultraconservative techniques together with the elaboration of adjuvant systemic therapies. This chapter charts the paradigm shifts in our conceptual understanding of breast cancer with their therapeutic consequences and concludes that the time is ripe for another paradigm shift and a new era of treatment that relies on chaos theory rather than an obsolete notion of linear dynamics to explain the “unpredictability” of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stewart I (1998) Life’s other secret: the new mathematics of the living world. Allen Lane the Penguin Press, London
Braithwaite PA, Shugg D (1983) Rembrandt’s Bathsheba: the dark shadow of the left breast. Ann R Coll Surg 65:337–339
Gross SW (1880) A practical treatise of tumours of the mammary gland. D. Appelton & Co., New York
Greenwood M (1926) A report on the natural duration of cancer: reports on public health and medical subjects, No. 33 H.M.S.O, London
Daland EM (1927) Untreated carcinoma of the breast. Surg Gynaecol Obstet 44:264–271
Bloom HJG (1968) Survival of women with untreated breast cancer-past and present. In: Forrest APM, Kunkler PB (eds) Prognostic factors in breast cancer. E&S Livingston Ltd, Edinburgh
Quinn MJ, Martinez-Garcia C, Berrino F (1998) Variations in survival from breast cancer in Europe by age and country, 1978-89. EUROCARE working group. Eur J Cancer 34:2204–2211
MacKay EN, Sellers AH (1965) Breast cancer at the Ontario Cancer Clinics, 1938–56: A statistical review. Medical statistics branch, Ontario department of health
Steckler RM, Martin RG (1973) Prolonged survival in untreated breast cancer. Am J Surg 126:111–119
Halsted WS (1894) The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Rep 4:297–350
DeMoulin D (1983) A short history of cancer. Martinus Nyhoff Publishers, Boston
Virchow R (1863–1873) Die Krankhaften Geschwulste, vol 1. Hirshwald Publishers, Berlin
Lewis D, WFJ R (1932) A study of results of operations for the cure of cancer of the breast. Ann Surg 95:336
Halsted WS (1924) The training of the surgeon. In: Halsted WS (ed) Surgical papers, vol 2. The Johns Hopkins Press, Baltimore
Urban J (1978) Management of operable breast cancer: the surgeon’s view. Cancer 42:2066
Meier P, Ferguson DJ, Karrison T (1985) A controlled trial of extended radical mastectomy. Cancer 55:880–891
Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C (1983) Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer 51:1941–1943
Brinkley D, Haybittle JL (1968) A 15 year follow up study of patients treated for carcinoma of the breast. Br J Radiol 41:215–221
Brinkley D, Haybittle JL (1975) The curability of breast cancer. Lancet 2:9–14
Fisher B (1980) Laboratory and clinical research in breast cancer: a personal adventure: the David a. Karnofsky memorial lecture. Cancer Res 40:3863–3874
Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy:133 randomized trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339(1–15):71–85
Early Breast Cancer Trialists’ Collaborative Group (1995) Effects of radiotherapy and surgery in early breast cancer. An overview of randomized trials. N Engl J Med 333:1444–1445
Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish breast cancer cooperative group 82b trial. N Engl J Med 337:949–955
Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956–962
Skipper HE (1971) Kinetics of mammary tumor cell growth and implications for therapy. Cancer 28:1479–1499
Frei EIII, Teicher B, Holden SA, Cathart KNS, Wang Y (1988) Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res 48:6417–6423
Frei EIII, Antman K, Teicher B, Eder P, Schnipper L (1989) Bone marrow autotransplantation for solid tumours—prospects. J Clin Oncol 7:515–526
Coleman RE, Rubens RD, Fogelman I (1988) Reappraisal of the baseline bone scan in breast cancer. J Nucl Med 29:1045–1049
Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31
Baum M, Badwe RA (1994) Does surgery influence the natural history of breast cancer? In: Wise H, Johnson HJ (eds) Breast cancer: controversies in management. Futura, Armonk, NY, pp 61–69
Schipper H, Turley EA, Baum M (1996) A new biological framework for cancer research. Lancet 348:1149–1151
Schipper H (1979) Historic milestones in cancer biology: a few that are important in cancer treatment. Semin Oncol 6:506–514
Baum M, Vaidya JS, Mittra I (1997) Multicentricity and recurrence of breast cancer. Lancet 349:208
Whitmore WFJ (1973) The natural history of prostate cancer. Cancer 32:1104–1112
Demicheli R, Retsky MW, Swartzendruber DE, Bonadonna G (1997) Proposal for a new model of breast cancer metastatic development. Ann Oncol 8:1075–1080
Baum M, Chaplain M, Anderson A, Douek M, Vaidya JS (1999) Does breast cancer exist in a state of chaos? Eur J Cancer 35:886–891
Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186
Folkman J, Watson K, Ingber D, Hanahan D (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58–61
Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? [editorial]. J Natl Cancer Inst 82:4–6
Douek M, Davidson T, Hall-Craggs MA et al (1997) Contrast enhancement MRI and tumour angiogenesis in breast cancer. Br J Surg 84:1588
Haran E, Maretzek A, Goldberg I, Horowitz A, Degani H (1994) Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelial growth. Cancer Res 54:5511–5514
Baum M, Benson JR (1996) Current and future roles of adjuvant endocrine therapy in management of early carcinoma of the breast. In: Senn HJ, Gelber RD, Goldhirsch A, Thurlimann B (eds) Recent results in cancer research—adjuvant therapy of breast cancer. Springer, Heidelberg, pp 215–226
Baum M (2015) Why does the weeping willow weep? Reconceptualizing oncogenesis in breast cancer. N Engl J Med 373(13):1267–1269
Lin J, Gunter LE, Harding SA et al (2007) Development of AFLP and RAPD markers linked to a locus associated with twisted growth in corkscrew willow (Salix matsudana ‘Tortuosa’). Tree Physiol 27(11):1575–1583
Huang LE, Bindra RS, Glazer PM, Harris AL (2007) Hypoxia-induced genetic instability—a calculated mechanism underlying tumor progression. J Mol Med 85:139–148
Di Ieva A, Grizzi F, Jelinek H, Pellionisz AJ, Losa GA (2014) Fractals in the neurosciences, Part I: general principles and basic neurosciences. Neuroscientist 20(4):403–417
Di Ieva A, Esteban FJ, Grizzi F, Klonowski W, Martín-Landrove M (2015) Fractals in the neurosciences, Part II: clinical applications and future perspectives. Neuroscientist 21(1):30–43
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Baum, M. (2017). The Natural History of Breast Cancer. In: Retsky, M., Demicheli, R. (eds) Perioperative Inflammation as Triggering Origin of Metastasis Development. Springer, Cham. https://doi.org/10.1007/978-3-319-57943-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-57943-6_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-57942-9
Online ISBN: 978-3-319-57943-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)